VivaVision's VVN461 Shows Promising Results in Phase 2 Trial for Non-Infectious Anterior Uveitis Treatment VivaVision Biotech celebrates significant success with VVN461, revealing promising efficacy and safety results in treating Non-Infectious Anterior Uveitis in their Phase 2 trial.

VivaVision's VVN461 Shows Promising Results in Phase 2 Trial for Non-Infectious Anterior Uveitis Treatment #China #VivaVision #VVN461 #Wenzhou #NIAU

Hello everyone ☺️

Who will I see today?
Z kim się widzimy?
Będzie sprawozdanie z konferencji 😊
#Przestrzeńdlazieleni
#SARP #NIAU